| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 37440 | Trends in Biotechnology | 2007 | 4 Pages |
Abstract
Mutasynthesis couples the power of chemical synthesis with molecular biology to generate derivatives of medicinally valuable, natural products. Recently, this technique has been exploited by Cambridge-based biotech company Biotica Technology Ltd, and their collaborators, to generate promising new variants of the polyketide anti-cancer compounds rapamycin and borrelidin.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Kira J. Weissman,